Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in Asthma Control in Obese/Overweight Children
NCT07622290Phase 3Not yet recruiting
- Start
- Jun 2026
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
A Phase 3 trial of liquid metformin (Aspargo Labs) in obesity-associated asthma. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
obesity-associated asthma
Beyond the preview
Go deeper on NCT07622290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07622290.